with the expected rate (Repert 1952) and an association was observed in a much larger series of 13 261 cancers (Dessaive 1956 ). Thyroid atrophy has been observed after breast cancer (Sommers 1955) . Some clinicians treat breast cancer with thyroid hormones (Loeser 1954 ).
Other studies have failed to support some of these findings. In one study the incidence of carcinoma was no different before or after thyroidectomy and the occurrence of thyroid disease in patients with breast cancer was no dif¬ ferent from that to be expected (Humphrey 8c Swerdlow 1964) euthyroidal function with age, sex, goitre size, and pre-menopausal or post-menopausal state (Oddie et al. 1960 Acland (1958) and normal values for the Sydney population are available (Radcliff et al. 1964) .
The classification of cases of primary cancer of the breast followed the principles set out by Portman (1943) 
RESULTS
The mean values of the four parameters studied are listed in Table 2 fa fa initial breast cancer, though these differences did not individually attain statistical significance. (Myhill 1965 (1960) .
In animal experiments the influence of thyroxine on the growth of some tumours has been clearly demonstrated (Weisburger 8c Weisburger 1958) , and indeed it has been observed that in tumour bearing animals the iodide space measured by retained iodide is increased (Scott 8c 
